Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
4.246
Zitationen
36
Autoren
2013
Jahr
Abstract
Abstract Background In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, and provided standardized terminology and diagnostic criteria. In addition, the historical “gold standard” of histologic diagnosis was replaced by a multidisciplinary approach. Since 2002 many publications have provided new information about IIPs. Purpose The objective of this statement is to update the 2002 ATS/ERS classification of IIPs. Methods An international multidisciplinary panel was formed and developed key questions that were addressed through a review of the literature published between 2000 and 2011. Results Substantial progress has been made in IIPs since the previous classification. Nonspecific interstitial pneumonia is now better defined. Respiratory bronchiolitis–interstitial lung disease is now commonly diagnosed without surgical biopsy. The clinical course of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia is recognized to be heterogeneous. Acute exacerbation of IIPs is now well defined. A substantial percentage of patients with IIP are difficult to classify, often due to mixed patterns of lung injury. A classification based on observed disease behavior is proposed for patients who are difficult to classify or for entities with heterogeneity in clinical course. A group of rare entities, including pleuroparenchymal fibroelastosis and rare histologic patterns, is introduced. The rapidly evolving field of molecular markers is reviewed with the intent of promoting additional investigations that may help in determining diagnosis, and potentially prognosis and treatment. Conclusions This update is a supplement to the previous 2002 IIP classification document. It outlines advances in the past decade and potential areas for future investigation.
Ähnliche Arbeiten
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
2011 · 7.244 Zit.
Interpretative strategies for lung function tests
2005 · 5.944 Zit.
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
2019 · 5.207 Zit.
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
2014 · 4.573 Zit.
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
2010 · 4.500 Zit.
Autoren
- William D. Travis
- Ulrich Costabel
- David M. Hansell
- Talmadge E. King
- David A. Lynch
- Andrew G. Nicholson
- Christopher J. Ryerson
- Jay H. Ryu
- Moisés Selman
- Athol U. Wells
- Jürgen Behr
- Demosthenes Bouros
- Kevin M. Brown
- Thomas V. Colby
- Harold R. Collard
- Carlos Robalo Cordeiro
- Vincent Cottin
- Bruno Crestani
- Marjolein Drent
- Rosalind F. Dudden
- Jim Egan
- Kevin R. Flaherty
- Cory M. Hogaboam
- Yoshikazu Inoue
- Takeshi Johkoh
- Dong Soon Kim
- Masanori Kitaichi
- James E. Loyd
- Fernando J. Martínez
- Jeffrey L. Myers
- Shandra Protzko
- Ganesh Raghu
- Luca Richeldi
- Nicola Sverzellati
- Jeffrey J. Swigris
- Dominique Valeyre
Institutionen
- Woolcock Institute of Medical Research(AU)
- University of Otago(NZ)
- University of Cape Town(ZA)
- University of California, San Francisco(US)
- Creighton University(US)
- Pulmonary and Critical Care Associates(US)
- University of Arizona(US)
- Erasmus University Rotterdam(NL)
- University of Groningen(NL)
- University of Edinburgh(GB)
- McMaster University(CA)
- Imperial College London(GB)
- University of Leicester(GB)
- University of Amsterdam(NL)
- University of Nevada, Reno(US)
- University of Washington(US)
- University of Aberdeen(GB)
- University of Pittsburgh(US)